Author | Siegelin, Markus David | dc.contributor.author |
Author | Schneider, Elisabeth | dc.contributor.author |
Author | Westhoff, Mike-Andrew | dc.contributor.author |
Author | Wirtz, Christian Rainer | dc.contributor.author |
Author | Karpel-Massler, Georg | dc.contributor.author |
Date of accession | 2021-04-12T09:35:06Z | dc.date.accessioned |
Available in OPARU since | 2021-04-12T09:35:06Z | dc.date.available |
Date of first publication | 2021 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | Drug repurposing | dc.subject |
Keyword | Malignant glioma | dc.subject |
Keyword | Glioblastoma | dc.subject |
Keyword | Drug cocktail | dc.subject |
Keyword | Multi-targeting | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | Current state and future perspective of drug repurposing in malignant glioma | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Institution | UKU. Klinik für Neurologie | uulm.affiliationSpecific |
Institution | UKU. Klinik für Kinder- und Jugendmedizin | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
DOI (external) | 10.1016/j.semcancer.2019.10.018 | dc.identifier.doiExternal |
Source - Title of source | Seminars in Cancer Biology | source.title |
Source - Place of publication | Elsevier | source.publisher |
Source - Volume | 68 | source.volume |
Source - Year | 2021 | source.year |
Source - From page | 92 | source.fromPage |
Source - To page | 104 | source.toPage |
Source - ISSN | 1044-579X | source.identifier.issn |
Source - eISSN | 1096-3650 | source.identifier.eissn |
Open Access | Bronze | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | 000616365300010 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |